[DNA breaks in the leukocytes and tumor cells as an indicator of therapeutic activity of cytostatics].
D003561:Cytarabine / Q000627:therapeutic use; D004247:DNA / Q000097:blood*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000097:blood* / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000097:blood* / Q000188:drug therapy; D007962:Leukocytes / Q000187:drug effects*; D008727:Methotrexate / Q000627:therapeutic use; D009691:Nucleic Acid Denaturation / Q000187:drug effects*
D003561:Cytarabine; D004247:DNA; D008727:Methotrexate
Povrezhedeniia DNK leĭkotsitov krovi i opukholevykh kletok kak pokazatel' terapevticheskoĭ aktivnosti tsitostaticheskikh preparatov.